Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (3): 304-308.DOI: 10.3969/j.issn.1673-8640.2021.03.015
Previous Articles Next Articles
WU Huiwen1, LI Luoping2, XING Xiaozhong2, WAN Dayong1
Received:
2020-08-04
Online:
2021-03-30
Published:
2021-03-30
CLC Number:
WU Huiwen, LI Luoping, XING Xiaozhong, WAN Dayong. Clinical value of combined detection of RBP,CRP and UMA in patients with chronic renal disease and ischemic cerebrovascular disease[J]. Laboratory Medicine, 2021, 36(3): 304-308.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.03.015
组别 | 例数 | 年龄/岁 | 体质量指数/(kg/m2) | 空腹血糖/(mmol/L) | 收缩压/kPa | 舒张压/kPa | 血红蛋白/ (g/L) |
---|---|---|---|---|---|---|---|
对照组 | 124 | 53.81±8.64 | 23.46±4.32 | 5.43±0.48 | 15.36±2.14 | 12.50±1.52 | 142.47±12.16 |
观察组 | 124 | 55.24±8.47 | 23.85±5.28 | 6.92±0.64 | 17.65±2.51 | 13.13±1.32 | 173.61±12.72 |
统计值 | 0.973 | 1.735 | 0.087 | 0.853 | 1.467 | 8.425 | |
P值 | 0.396 | 0.337 | 0.753 | 0.397 | 0.161 | 0.132 | |
组别 | 血浆白蛋白/ (g/L) | 总胆固醇/ (mmol/L) | 三酰甘油/ (mmol/L) | 高密度脂蛋白胆固 醇/(mmol/L) | 低密度脂蛋白胆固 醇/(mmol/L) | 肌酐/ (μmol/L) | |
对照组 | 38.53±5.67 | 4.17±1.34 | 1.56±0.75 | 1.27±0.44 | 2.41±0.62 | 73.73±6.46 | |
观察组 | 42.28±4.74 | 4.46±1.51 | 1.69±0.42 | 1.31±0.38 | 2.33±0.75 | 86.26±7.38 | |
统计值 | 2.646 | 0.574 | 0.362 | 1.834 | 1.173 | 6.427 | |
P值 | 0.075 | 0.329 | 0.594 | 0.125 | 0.431 | 1.362 | |
组别 | D-二聚体/ (mg/L) | 尿素氮/ (mmol/L) | 尿酸/ (μmol/L) | RBP/ (mg/L) | CRP/ (mg/L) | UMA/ (mg/L) | |
对照组 | 0.37±0.18 | 5.93±1.61 | 284.17±56.35 | 45.47±11.53 | 7.24±2.43 | 94.42±3.92 | |
观察组 | 0.45±0.25 | 6.27±1.76 | 358.36±64.62 | 84.32±13.84 | 12.53±2.91 | 143.21±24.16 | |
统计值 | 2.841 | 0.728 | 7.547 | 5.318 | 2.637 | 6.934 | |
P值 | 0.086 | 0.114 | 0.061 | 0.019 | 0.047 | 0.026 |
组别 | 例数 | 年龄/岁 | 体质量指数/(kg/m2) | 空腹血糖/(mmol/L) | 收缩压/kPa | 舒张压/kPa | 血红蛋白/ (g/L) |
---|---|---|---|---|---|---|---|
对照组 | 124 | 53.81±8.64 | 23.46±4.32 | 5.43±0.48 | 15.36±2.14 | 12.50±1.52 | 142.47±12.16 |
观察组 | 124 | 55.24±8.47 | 23.85±5.28 | 6.92±0.64 | 17.65±2.51 | 13.13±1.32 | 173.61±12.72 |
统计值 | 0.973 | 1.735 | 0.087 | 0.853 | 1.467 | 8.425 | |
P值 | 0.396 | 0.337 | 0.753 | 0.397 | 0.161 | 0.132 | |
组别 | 血浆白蛋白/ (g/L) | 总胆固醇/ (mmol/L) | 三酰甘油/ (mmol/L) | 高密度脂蛋白胆固 醇/(mmol/L) | 低密度脂蛋白胆固 醇/(mmol/L) | 肌酐/ (μmol/L) | |
对照组 | 38.53±5.67 | 4.17±1.34 | 1.56±0.75 | 1.27±0.44 | 2.41±0.62 | 73.73±6.46 | |
观察组 | 42.28±4.74 | 4.46±1.51 | 1.69±0.42 | 1.31±0.38 | 2.33±0.75 | 86.26±7.38 | |
统计值 | 2.646 | 0.574 | 0.362 | 1.834 | 1.173 | 6.427 | |
P值 | 0.075 | 0.329 | 0.594 | 0.125 | 0.431 | 1.362 | |
组别 | D-二聚体/ (mg/L) | 尿素氮/ (mmol/L) | 尿酸/ (μmol/L) | RBP/ (mg/L) | CRP/ (mg/L) | UMA/ (mg/L) | |
对照组 | 0.37±0.18 | 5.93±1.61 | 284.17±56.35 | 45.47±11.53 | 7.24±2.43 | 94.42±3.92 | |
观察组 | 0.45±0.25 | 6.27±1.76 | 358.36±64.62 | 84.32±13.84 | 12.53±2.91 | 143.21±24.16 | |
统计值 | 2.841 | 0.728 | 7.547 | 5.318 | 2.637 | 6.934 | |
P值 | 0.086 | 0.114 | 0.061 | 0.019 | 0.047 | 0.026 |
项目 | 真阳性/例 | 假阳性/例 | 假阴性例 | 真阴性/例 | 敏感性/% |
---|---|---|---|---|---|
RBP | 112 | 9 | 11 | 116 | 90.32 |
CRP | 106 | 7 | 14 | 121 | 85.48 |
UMA | 108 | 5 | 17 | 118 | 87.10 |
联合检测 | 117 | 12 | 6 | 113 | 94.35 |
项目 | 真阳性/例 | 假阳性/例 | 假阴性例 | 真阴性/例 | 敏感性/% |
---|---|---|---|---|---|
RBP | 112 | 9 | 11 | 116 | 90.32 |
CRP | 106 | 7 | 14 | 121 | 85.48 |
UMA | 108 | 5 | 17 | 118 | 87.10 |
联合检测 | 117 | 12 | 6 | 113 | 94.35 |
组别 | 例数 | 年龄/岁 | 体质量指数/(kg/m2) | 空腹血糖/(mmol/L) | 收缩压/kPa | 舒张压/kPa | 血红蛋白/ (g/L) |
---|---|---|---|---|---|---|---|
预后良好组 | 81 | 52.46±9.34 | 22.31±3.82 | 5.46±0.42 | 17.35±1.29 | 12.87±1.30 | 152.67±12.35 |
预后不良组 | 43 | 54.17±8.23 | 23.14±4.37 | 6.63±0.58 | 19.08±1.61 | 13.17±1.54 | 178.26±13.28 |
统计值 | 0.683 | 1.175 | 0.093 | 0.967 | 1.932 | 8.383 | |
P值 | 0.362 | 0.193 | 0.746 | 0.435 | 0.135 | 0.073 | |
组别 | 血浆白蛋白/ (g/L) | 总胆固醇/ (mmol/L) | 三酰甘油/ (mmol/L) | 高密度脂蛋白胆固 醇/(mmol/L) | 低密度脂蛋白胆固 醇/(mmol/L) | 肌酐/ (μmol/L) | |
预后良好组 | 34.81±5.15 | 4.46±1.28 | 1.79±0.44 | 1.39±0.13 | 2.47±0.64 | 90.27±8.53 | |
预后不良组 | 39.64±4.84 | 4.71±1.43 | 1.87±0.32 | 1.26±0.27 | 2.35±0.85 | 88.62±8.28 | |
统计值 | 1.261 | 0.363 | 0.525 | 2.346 | 1.492 | 7.273 | |
P值 | 0.056 | 0.724 | 0.493 | 0.171 | 0.239 | 2.816 | |
组别 | D-二聚体/ (mg/L) | 尿素氮/ (mmol/L) | 尿酸/ (μmol/L) | RBP/ (mg/L) | CRP/ (mg/L) | UMA/ (mg/L) | |
预后良好组 | 0.47±0.24 | 5.44±1.76 | 281.36±53.52 | 62.57±14.83 | 10.84±2.58 | 134.12±17.74 | |
预后不良组 | 0.65±0.27 | 6.16±1.84 | 329.43±58.15 | 114.31±20.26 | 17.61±3.29 | 159.75±19.28 | |
统计值 | 0.631 | 2.235 | 1.753 | 7.273 | 2.961 | 4.347 | |
P值 | 0.534 | 0.183 | 3.436 | 0.009 | 0.033 | 0.041 |
组别 | 例数 | 年龄/岁 | 体质量指数/(kg/m2) | 空腹血糖/(mmol/L) | 收缩压/kPa | 舒张压/kPa | 血红蛋白/ (g/L) |
---|---|---|---|---|---|---|---|
预后良好组 | 81 | 52.46±9.34 | 22.31±3.82 | 5.46±0.42 | 17.35±1.29 | 12.87±1.30 | 152.67±12.35 |
预后不良组 | 43 | 54.17±8.23 | 23.14±4.37 | 6.63±0.58 | 19.08±1.61 | 13.17±1.54 | 178.26±13.28 |
统计值 | 0.683 | 1.175 | 0.093 | 0.967 | 1.932 | 8.383 | |
P值 | 0.362 | 0.193 | 0.746 | 0.435 | 0.135 | 0.073 | |
组别 | 血浆白蛋白/ (g/L) | 总胆固醇/ (mmol/L) | 三酰甘油/ (mmol/L) | 高密度脂蛋白胆固 醇/(mmol/L) | 低密度脂蛋白胆固 醇/(mmol/L) | 肌酐/ (μmol/L) | |
预后良好组 | 34.81±5.15 | 4.46±1.28 | 1.79±0.44 | 1.39±0.13 | 2.47±0.64 | 90.27±8.53 | |
预后不良组 | 39.64±4.84 | 4.71±1.43 | 1.87±0.32 | 1.26±0.27 | 2.35±0.85 | 88.62±8.28 | |
统计值 | 1.261 | 0.363 | 0.525 | 2.346 | 1.492 | 7.273 | |
P值 | 0.056 | 0.724 | 0.493 | 0.171 | 0.239 | 2.816 | |
组别 | D-二聚体/ (mg/L) | 尿素氮/ (mmol/L) | 尿酸/ (μmol/L) | RBP/ (mg/L) | CRP/ (mg/L) | UMA/ (mg/L) | |
预后良好组 | 0.47±0.24 | 5.44±1.76 | 281.36±53.52 | 62.57±14.83 | 10.84±2.58 | 134.12±17.74 | |
预后不良组 | 0.65±0.27 | 6.16±1.84 | 329.43±58.15 | 114.31±20.26 | 17.61±3.29 | 159.75±19.28 | |
统计值 | 0.631 | 2.235 | 1.753 | 7.273 | 2.961 | 4.347 | |
P值 | 0.534 | 0.183 | 3.436 | 0.009 | 0.033 | 0.041 |
项目 | 回归系数 | 标准误 | Wald 值 | P值 | 比值比 | 95%可信区间 |
---|---|---|---|---|---|---|
RBP | 0.931 | 0.348 | 6.745 | 0.023 | 1.417 | 1.106~3.257 |
CRP | 1.372 | 0.529 | 8.163 | 0.007 | 1.851 | 1.032~2.624 |
UMA | 0.615 | 0.142 | 3.826 | 0.012 | 1.273 | 1.014~2.146 |
项目 | 回归系数 | 标准误 | Wald 值 | P值 | 比值比 | 95%可信区间 |
---|---|---|---|---|---|---|
RBP | 0.931 | 0.348 | 6.745 | 0.023 | 1.417 | 1.106~3.257 |
CRP | 1.372 | 0.529 | 8.163 | 0.007 | 1.851 | 1.032~2.624 |
UMA | 0.615 | 0.142 | 3.826 | 0.012 | 1.273 | 1.014~2.146 |
[1] | 马红雨, 董磊, 全首祯, 等. 视黄醇结合蛋白、血清胱抑素C在慢性肾脏病中的诊断价值[J]. 空军医学杂志, 2018,34(1):45-47. |
[2] | 陈香美, 孙雪峰, 蔡广研. 我国慢性肾脏病防治的公共健康政策思考[J]. 中华医学杂志, 2014,94(4):241-243. |
[3] | 孟令栋, 刘昌华, 伍刚. 慢性肾脏病研究进展[J]. 山西医药杂志, 2017,46(10):1170-1172. |
[4] |
VINOD K V, VERMA S P, KARTHIKEYAN B, et al. Cerebral infarction leading to hemiplegia:a rare complication of acute pancreatitis[J]. Indian J Crit Care Med, 2013,17(5):308-310.
DOI URL PMID |
[5] | 徐东升, 王引明, 殷晓菁, 等. 缺血性脑血管病患者血清RBP水平与颈动脉粥样硬化斑块的相关性研究[J]. 中风与神经疾病杂志, 2017,34(2):115-118. |
[6] | 宗黎霞, 朱以诚, 崔丽英. 慢性肾脏病与脑血管病变相关性的研究进展[J]. 中华神经科杂志, 2015,48(1):76-78. |
[7] | 蒋燕萍, 曾玉萍, 吴波. 脑血管病临床研究进展[J]. 中国现代神经疾病杂志, 2018,18(2):89-94. |
[8] |
NAST C C. Infection-related glomerulonephritis:changing demographics and out comes[J]. Adv Chronic Kidney Dis, 2012,19(2):68-75.
URL PMID |
[9] |
FERGUSON M A, WAIKAR S S. Established and emerging markers of kidney function[J]. Clin Chem, 2012,58(4):680-689.
DOI URL PMID |
[10] | 陈鹏, 王小琴, 王岚, 等. 尿微量蛋白联合检测对慢性肾病早期肾损伤诊断的临床应用价值[J]. 中国医药导报, 2019,16(29):118-123. |
[11] | 刘晶, 唐晓红, 李孜. C反应蛋白与肾脏疾病发病机制的研究进展[J]. 中国中西医结合肾病杂志, 2019,20(9):837-839. |
[12] | National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J]. Am J Kidney Dis, 2002,39(Suppl 2) : S1-S266. |
[13] | 彭斌, 吴波. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018,51(9):666-682. |
[14] | 谈颂, 常思远, 宋波, 等. 早期改良美国国立卫生研究院卒中量表评分对缺血性卒中预后的预测作用[J]. 中华神经科杂志, 2012,45(3):154-157. |
[15] | 刘强, 胡冰凌, 周勇, 等. 慢性肾脏病与缺血性卒中短期预后的关系[J]. 南昌大学学报(医学版), 2016,56(3):56-60. |
[16] |
WANG X, LUO Y, WANG Y, et al. Comparison of associations of outcomes after stroke with estimated GFR using Chinese modifications of the MDRD study and CKD-EPI creatinine eguations:result from the China National Stroke Registry[J]. Am J Kidney Dis, 2014,63(1):59-67.
DOI URL PMID |
[17] | 赖鑫. 血清胱抑素C联合尿RBP检验在糖尿病患者早期肾损伤中的价值[J]. 中国当代医药, 2017,24(18):109-110. |
[18] | 秦雪, 吴钦良, 王兵, 等. TRF、RBP在慢性肾功能不全患者诊疗中的临床价值[J]. 临床血液学杂志, 2019,32(2):130-132. |
[19] | 闻玉晶. 脑梗塞、脑出血患者血清C-反应蛋白水平的变化及临床意义[J]. 世界最新医学信息文摘(连续型电子期刊), 2014,14(32):247. |
[20] | 翟志永, 高岩, 韩冬, 等. 小血管病变所致急性腔隙性脑梗死与尿微量白蛋白的相关性研究[J]. 中国脑血管病杂志, 2014,11(9):480-484. |
[21] |
KAMOUCHI M. Stroke features and management in patients with chronic kidney disease[J]. Contrib Nephrol, 2013,179:92-99.
DOI URL PMID |
[1] | WU Caorong, CUI Wen, TANG Binbin, HE Jingjing, LAI Zhikun. Correlations between the ratio of C-reactive protein to prealbumin and the prognosis of patients with acute heart failure [J]. Laboratory Medicine, 2023, 38(6): 579-583. |
[2] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[3] | LI Dongxiu, HUANG Jian. Roles of serum sICAM-1 and hs-CRP levels in monitoring acute viral lower respiratory tract infection in children [J]. Laboratory Medicine, 2022, 37(3): 226-229. |
[4] | SONG Yunxiao, TONG Wei, ZHANG Haichen, ZHANG Yinwang, BIAN Xiaobo, ZHANG Linlin, YUAN Wenhua, ZHAO Zhiyun, GE Wen, YAO Tianyue. Correlation of systemic inflammatory markers and fracture occurrence in elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(3): 235-239. |
[5] | YAO Hualong. Roles of PTH,CRP,OPG/PYR ratio in elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(12): 1146-1150. |
[6] | HE Xuelian, HE Ziyi, LIU Yueyang, YU Yanzhi, ZHANG Siying. Role of line chart model based on peripheral blood-derived inflammation markers in early diagnosis of neonatal septicemia [J]. Laboratory Medicine, 2022, 37(10): 921-927. |
[7] | LIU Chunxiao, YI Changlin, WANG Xiaoshan, ZHU Yongzhen, LUO Aner, CHEN Changqiang. Roles of MxA,CRP and WBC count in the differential diagnosis of acute respiratory tract viral and bacterial infections [J]. Laboratory Medicine, 2022, 37(10): 944-947. |
[8] | XIONG Zhongbo, WANG Lei, YIN Beiqi, DAI Yue, WEI Xiaoqing, LU Pei. Clinical roles of SAA and CRP in pathological staging and metastasis of gastrointestinal cancer [J]. Laboratory Medicine, 2022, 37(1): 51-55. |
[9] | KONG Fanbin, YUAN Yong, JI Yong, LI Zheng, CHEN Qi, WU Xiaoming, GAO Hui. Correlation between serum retinol binding protein 4,homocysteine and blood lipid with atherosclerosis [J]. Laboratory Medicine, 2021, 36(5): 467-470. |
[10] | XIE Hui, SHEN Han. Changes of coagulation function and influence factors of hypercoagulability in patients with chronic kidney disease [J]. Laboratory Medicine, 2021, 36(5): 500-503. |
[11] | WANG Qian, ZHU Shiyao, LU Di, ZHU Kun, WU Jiong, QUAN Jiali. Arteriosclerotic cardiovascular disease risk markers research progress [J]. Laboratory Medicine, 2021, 36(4): 447-452. |
[12] | WANG Kehui, HUANG Yun, ZHANG Zhengyin, WANG Yating, XUE Yuqin, CAI Sufang, FAN Chao, JIN Ying, ZHENG Yijing, CHANG Jinfeng. Clinical diagnostic value of serum allergen,IL-6 and CRP levels in patients with acute urticaria [J]. Laboratory Medicine, 2021, 36(3): 300-303. |
[13] | ZHU Chuanxin, ZHOU Yuping, HE Yan, ZHOU Qin. Diagnostic role of NLR,CRP,PCT,DD and NT-proBNP in severe corona virus disease 2019 [J]. Laboratory Medicine, 2021, 36(2): 190-193. |
[14] | Clinical Diagnosis and Laboratory Medicine Branch of China Maternal and Child Health Association. Expert consensus on establishment of standards for the performance evaluation of systems for whole blood C-reactive protein determination of Chinese children [J]. Laboratory Medicine, 2021, 36(12): 1201-1205. |
[15] | ZHAO Jingjing, ZHANG Peng, ZHOU Yong, CAO Yingping, HUANG Zhihu, FU Shengmiao, WANG Yuming, HONG Guolin, SHEN Jun, ZHENG Lei. A preliminary study on Lp-PLA2 and its relationship with LDL-C and hs-CRP in southern China [J]. Laboratory Medicine, 2021, 36(12): 1222-1228. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||